Design potential selective inhibitors for human leukocyte common antigen-related (PTP-LAR) with fragment replace

Jing-Wei Wu1, Huan Zhang2, Wei-Ya Li1

  • 1Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, China.